On-Demand Webinars

  1. Selecting Container Closure Systems With Confidence: Lyophilization 3/7/2024

    Experts take you through the entire selection process for primary packaging components for lyophilization and provide aspects to consider for all relevant attributes.

  2. Solid Form Screening Of Active Pharmaceutical Ingredients

    Explore the role of solid form services in helping meet accelerated timelines of the drug development lifecycle along with examples of robust workflows for fast and thorough solid form screens.

  3. De-Risking The Aseptic Drug-Filling Process And Optimizing Production 4/17/2024

    Aseptic drug-filling poses significant risks for manufacturers that can increase costs and timelines. Leveraging proven expertise and efficiency can ensure the production of safe, efficacious products.

  4. Navigating Primary Packaging Challenges, Solutions For Emerging Innovators 12/5/2024

    If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.

  5. Continuous Flow Techniques For Fine Chemical Manufacturing

    Explore the advantages and challenges of continuous flow processes and the concept of mini-monoplant technology, along with examples that demonstrate the versatility of continuous processing.

  6. Identify And Mitigate Absorption Risks With PBPK Modeling 3/12/2024

    See how PBPK models combined with custom and off-the-shelf in vitro tools and solubility enhancement expertise can reduce the need for drug product reformulation or repeated preclinical or clinical studies.

  7. Manufacturing Strategies And Facility Design For Patient-Centric Delivery 11/21/2024

    Review how to select the optimal manufacturing strategy and leverage technologies for efficient and scalable production of therapeutic proteins. De-risk the supply chain, accelerate time to market, and reduce costs.

  8. Advanced Analytical Tools For Drug Product Development

    Gain insights on the applications of analytical techniques including Raman spectroscopy, nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS).

  9. Accelerating Nasal Dosage Form Development From Early-Phase To Clinical Trial Manufacture 10/21/2024

    Led by Dr. Richard Johnson, Chief Scientific Officer, this 40-minute session covers the five key stages of the UpperNose development platform, highlighting the significance of target product selection and its influence on formulation and clinical outcomes.

  10. De-Risking Development With Analytical Characterization Capabilities 3/13/2024

    Review the advancing mass spectrometry, biophysical characterization, automated sample preparation, and high throughput analytics required to deliver medicines in a safe, compliant, and efficient manner.